SLXN Earnings Silexion Therapeutics Corp
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–12 of 12
| Q1 2026 | 2026-03-31 | 0.85 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | 8.96 | 2026-03-17 | 10-K |
| Q3 2025 | 2025-09-30 | 10.36 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | 8.21 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | 3.84 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | 394.94 | 2026-03-17 | 10-K |
| Q3 2025 | 2024-09-30 | 754.85 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | 381.09 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | 12.29 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | 44.23 | 2025-03-18 | 10-K |
| Q3 2024 | 2023-09-30 | 3.20 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | 9.61 | 2024-08-29 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.